{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:20:30Z","timestamp":1787019630975,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-230x-11-30","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T02:23:21Z","timestamp":1302056601000},"source":"Crossref","is-referenced-by-count":17,"title":["Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report"],"prefix":"10.1186","volume":"11","author":[{"given":"Cristina","family":"Popescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Arama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaranda","family":"Gliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"key":"566_CR1","doi-asserted-by":"publisher","first-page":"112S","DOI":"10.1002\/hep.510260720","volume":"26","author":"G Dusheiko","year":"1997","unstructured":"Dusheiko G: Side effects of alpha interferon in chronic hepatitis C. Hepatology. 1997, 26: 112S-121S. 10.1002\/hep.510260720.","journal-title":"Hepatology"},{"key":"566_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bpg.2009.10.012","volume":"24","author":"F Negro","year":"2010","unstructured":"Negro F: Adverse effects of drugs in the treatment of viral hepatitis. Best Pract Res Clin Gastroenterol. 2010, 24: 183-92. 10.1016\/j.bpg.2009.10.012.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"566_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30: 239-45. 10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"key":"566_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","volume":"23","author":"YJ Liu","year":"2005","unstructured":"Liu YJ: IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005, 23: 275-306. 10.1146\/annurev.immunol.23.021704.115633.","journal-title":"Annu Rev Immunol"},{"key":"566_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.20452\/pamw.75","volume":"117","author":"T Rechci\u0144ski","year":"2007","unstructured":"Rechci\u0144ski T, Matusik D, Rudzi\u0144ski T, et al: Cardiotoxic properties of interferon: aggravation of atrio-ventricular block during treatment of chronic hepatitis C with peginterferon--a case report. Pol Arch Med Wewn. 2007, 117: 49-52.","journal-title":"Pol Arch Med Wewn"},{"key":"566_CR6","doi-asserted-by":"crossref","unstructured":"Outzen MA, Crowley S: Interferons Play a Central Role in the Natural Defense and Therapeutic Management of Hepatitis C: A Review. The Internet Journal of Gastroenterology. 2007, 5 (2):","DOI":"10.5580\/13a6"},{"key":"566_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/ajh\/5.4.224","volume":"5","author":"H Takahashi","year":"1992","unstructured":"Takahashi H, Nishimura M, Sakamoto M, Ikegaki I, Nakanishi T, Yoshimura M: Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats. Am J Hypertens. 1992, 5: 224-9.","journal-title":"Am J Hypertens"},{"key":"566_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ehj.2004.02.002","volume":"25","author":"B Maisch","year":"2004","unstructured":"Maisch B, Seferovi\u0107 PM, Risti\u0107 AD, et al: Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004, 25: 587-610. 10.1016\/j.ehj.2004.02.002.","journal-title":"Eur Heart J"},{"key":"566_CR9","first-page":"486","volume":"9","author":"O Benjamini","year":"2007","unstructured":"Benjamini O, Kimhi O, Lishner M: Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b. Isr Med Assoc J. 2007, 9: 486-7.","journal-title":"Isr Med Assoc J"},{"key":"566_CR10","first-page":"484","volume":"81","author":"S Fava","year":"1996","unstructured":"Fava S, Luoni M, Stioui S: Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia. Haematologica. 1996, 81: 484-","journal-title":"Haematologica"},{"key":"566_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/08860220701641579","volume":"29","author":"A Sikole","year":"2007","unstructured":"Sikole A, Dzekova P, Selja N, et al: Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy. Ren Fail. 2007, 29: 961-6. 10.1080\/08860220701641579.","journal-title":"Ren Fail"},{"key":"566_CR12","first-page":"325","volume":"192","author":"A Su\u00e1rez","year":"1993","unstructured":"Su\u00e1rez A, Vallina E, Navascu\u00e9s CA, et al: Mixed type-II cryoglobulinemia associated with a chronic hepatitis C virus infection. Rev Clin Esp. 1993, 192: 325-6.","journal-title":"Rev Clin Esp"},{"key":"566_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s100670050081","volume":"18","author":"A Boonen","year":"1999","unstructured":"Boonen A, Stockbr\u00fcgger RW, van der Linden S: Pericarditis after therapy with interferon-alpha for chronic hepatitis. C Clin Rheumatol. 1999, 18: 177-9. 10.1007\/s100670050081.","journal-title":"C Clin Rheumatol"},{"key":"566_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4254\/wjh.v2.i9.358","volume":"2","author":"Kazuaki Nishio","year":"2010","unstructured":"Nishio Kazuaki, Konndo Takeshi, Shunichi Okada, et al: Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C. World J Hepatol. 2010, 2: 358-61. 10.4254\/wjh.v2.i9.358.","journal-title":"World J Hepatol"},{"key":"566_CR15","first-page":"301","volume":"67","author":"B Gressens","year":"2004","unstructured":"Gressens B, Gohy P: Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C. Acta Gastroenterol Belg. 2004, 67: 301-2.","journal-title":"Acta Gastroenterol Belg"},{"key":"566_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0399-8320(04)94929-9","volume":"28","author":"B Wisniewski","year":"2004","unstructured":"Wisniewski B, Denis J, Fischer D, Labayle D: Pericarditis secondary to interferon alpha in chronic hepatitis C. Gastroenterol Clin Biol. 2004, 28: 315-6. 10.1016\/S0399-8320(04)94929-9.","journal-title":"Gastroenterol Clin Biol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-11-30\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T17:22:13Z","timestamp":1741108933000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-11-30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-11-30","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]},"article-number":"30"}}